Overview Platelet Rich Plasma in Plantar Fasciitis Status: Recruiting Trial end date: 2022-07-01 Target enrollment: Participant gender: Summary a number of patient diagnosed as degenerative plantar fasciitis will be collected and divided into two groups, group I will be injected by platelet rich plasma and group II will be injected methylprednisolone Phase: N/A Details Lead Sponsor: Minia UniversityTreatments: LidocaineMethylprednisoloneMethylprednisolone AcetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate